Document ID: chunk:federal_register_of_legislation:F2024L00749:reg:9:p1
Version: federal_register_of_legislation:F2024L00749
Segment Type: reg
Provision Reference: reg 9 (pt 1/3)
Character Range: 4162–7259

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting duodenal ulcer and duodenal erosion or death from duodenal ulcer and duodenal erosion with the circumstances of a person's relevant service:
(1)          being a prisoner of war before clinical onset or clinical worsening;
(2)          having Helicobacter pylori infection of the duodenum at the time of clinical onset or clinical worsening;
(3)          having an infection of the duodenal mucosa by one of the following organisms:
(a)          Anisakis simplex (causing anisakiasis);
(b)          cytomegalovirus;
(c)          herpes simplex virus;
(d)          fungi (such as Candida species or Histoplasma capsulatum);
(e)          Helicobacter heilmannii;
(f)           Mycobacterium tuberculosis;
(g)          Strongyloides stercoralis (causing strongyloidiasis); or
(h)          Treponema pallidum infection (causing syphilis);
at the time of clinical onset or clinical worsening;
(4)          having a critical illness or injury within the 30 days before clinical onset or clinical worsening;
Note: critical illness or injury is defined in the Schedule 1 - Dictionary.
(5)          undergoing a course of radiotherapy for cancer, where the stomach or duodenum was in the field of radiation, within the one year before clinical onset or clinical worsening;
(6)          having received a cumulative equivalent dose of at least 10 sieverts of ionising radiation to the stomach or duodenum within the one year before clinical onset or clinical worsening;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(7)          undergoing 90Yttrium microsphere therapy for primary and metastatic liver tumours, within the one year before clinical onset or clinical worsening;
(8)          having contact with a nasogastric tube or other foreign objects or extraneous material at the site of the ulcer or erosion at the time of clinical onset or clinical worsening;
(9)          having Roux-en-Y gastric bypass within the 5 years before clinical onset or clinical worsening of duodenal ulcer or duodenal erosion, where the ulcer or erosion occurred at the site of the surgical anastomosis;
(10)      having a gastrin-secreting tumour at the time of clinical onset or clinical worsening;
(11)      smoking at least 10 cigarettes per day, or the equivalent thereof in other tobacco products, for at least the 12 months before clinical onset or clinical worsening;
(12)      being treated with a non-topical non-steroidal anti-inflammatory drug, or aspirin, at least every other day during a continuous period of at least 8 days, within the 3 months before clinical onset or clinical worsening;
(13)      having a solid organ or bone marrow transplant before clinical onset or clinical worsening;
(14)      being treated with an antineoplastic agent within the 3 months before clinical onset or clinical worsening;
Note: antineoplastic agent is defined in the Schedule 1 - Dictionary.
(15)      being